Modulation Effect of Peroxisome Proliferator-Activated Receptor Agonists on Lipid Droplet Proteins in Liver

Peroxisome proliferator-activated receptor (PPAR) agonists are used for treating hyperglycemia and type 2 diabetes. However, the mechanism of action of these agonists is still under investigation. The lipid droplet-associated proteins FSP27/CIDEC and LSDP5, regulated directly by PPARγ and PPARα, are...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yun-Xia, Zhang, Ming-Liang, Zhong, Yuan, Wang, Chen, Jia, Wei-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684860/
https://www.ncbi.nlm.nih.gov/pubmed/26770990
http://dx.doi.org/10.1155/2016/8315454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684860/
https://www.ncbi.nlm.nih.gov/pubmed/26770990
http://dx.doi.org/10.1155/2016/8315454

Ejemplares similares